Discover
GRCE
Grace Therapeutics, Inc.
2.24
2 x 1.64
2 x 2.85
bid
ask
-
0.03
1.32%
2 @ 04:00 PM
2.25 +0.01 (0.45%)
| Ytd | -35.26% | |
| 1y | -24.32% |
2.22
day range
2.34
1.79
52 week range
5.18
| Open | 2.25 | Prev Close | 2.27 | Low | 2.22 | High | 2.34 | Mkt Cap | 36.45M |
| Vol | 249.70K | Avg Vol | 712.75K | EPS | -0.47 | P/E | N/A | Forward P/E | -2.90 |
| Beta | 1.51 | Short Ratio | 3.25 | Inst. Own | 21.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 06-20 | 50-d Avg | 2.39 | 200-d Avg | 3.27 | 1yr Est | 10.44 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2025-02-10 | 2024-12 | -0.27 | N/A | N/A | N/A |
| 2024-11-13 | 2024-09 | -0.33 | -0.33 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Adar1 Capital Management, LLC | 959.57K | 3.51M | 9.46% |
| 2024-09-29 | AIGH Capital Management LLC | 641.08K | 2.35M | 6.32% |
| 2024-09-29 | Bank of America Corporation | 494.70K | 1.81M | 4.88% |
| 2024-09-29 | Renaissance Technologies, LLC | 16.15K | 59.10K | 0.16% |
| 2024-09-29 | National Bank of Canada/FI | 2.72K | 9.95K | 0.03% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 2.73K | 10.00K | 0.03% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 3.06K | 11.19K | 0.03% |